US Army leadership says it wants soldiers out figuring out what's needed for war, not 'focused on things like PowerPoint slides' Broncos coach Sean Payton issues warning about Shedeur Sanders ...

"This [the patenting of NGTs] can favour large biotech companies. And I think one of the spirits of this new regulation is to enlarge the access to new partners, smaller industries, public industries, ...

Proficiency in basic productivity tools such as Microsoft Office (Word, Excel, PowerPoint), Microsoft Teams ... The School of Chemistry, Chemical Engineering and Biotechnology seeks a diverse and ...

Biotechnology company Regeneron will acquire 23andMe out of bankruptcy for $256 million, with a plan to keep the DNA-testing company running without interruption and uphold its privacy-protection ...

So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker. As always, if you know of a layoff occurring at a biotech, please reach out to the Fierce Biotech editorial team ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...

A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last ...

LONDON (Reuters) -Some U.S. biotech companies are considering moving early-stage trials of new medicines outside the United States as worry grows that layoffs and policy changes at the drugs ...

By Michael Levenson 23andMe, the genetic testing company that was once valued at $6 billion but filed for bankruptcy in March, will be bought by Regeneron Pharmaceuticals, a biotechnology company ...

If he could control these microscopic snips, UC Berkeley historian Sally Smith Hughes writes in her book, Genentech: The Beginnings of Biotech, he could manipulate “the stuff of life.” Within six ...

But today, Kendall has been reborn — as the glittering, glassy heart of America’s biotech industry. For many companies, Kendall Square’s status as a global center of biotechnology firms and ...

Two biotech stocks make perfect candidates for this sort of strategy right now. One has declined over the past four years, while the other just slipped in recent weeks. Each represents a bargain ...